LON:TSTL
Tristel Plc
Position levels
Currenttoday
431.91p
Buy <=wait / entry
380.00p
Trim >=take some off
460.00p
Thesis breakUS medical device regulatory approval is denied or materially delayed beyond 12 ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 33% | 100 / 100 | 33.0 |
| Base case | 51% | 62 / 100 | 31.6 |
| Bear case | 16% | 10 / 100 | 1.6 |
| Weighted conviction | 66 / 100 - BUY | ||
Top risks
- OEM collaborations and expanding distribution partnerships supporting US product launches
- Sixfold US revenue growth from commercial launch of high-level disinfection products for ultrasound and ophthalmology
- H1 FY2026 record revenue of GBP 25.6m (+14%) and adjusted EBITDA +17% with 29% margins